StockNews.com lowered shares of Exelon (NASDAQ:EXC – Get Rating) from a hold rating to a sell rating in a research report sent to investors on Tuesday. A number of other equities analysts have also weighed in on the company. BMO Capital Markets decreased their price target on Exelon from $46.00 to $44.00 in a research […]